Effect of the COVID-19 Pandemic on Paediatric Check-Ups and Vaccinations in Germany
- PMID: 37112632
- PMCID: PMC10145570
- DOI: 10.3390/vaccines11040720
Effect of the COVID-19 Pandemic on Paediatric Check-Ups and Vaccinations in Germany
Abstract
Paediatric check-ups and vaccinations are provided and free of charge in Germany. Despite being hitherto generally well-received and adhered to, it is possible that the lockdown implemented due to the COVID-19 pandemic resulted in delays or even cancellations of critical paediatric visits with healthcare providers. This study attempts to quantify the rate and time to follow-up for check-ups in Germany using the retrospective IQVIATM Disease Analyzer database. Additionally, timely administration of 4 vaccines (Hexavalent, pneumococcal, MMR-V, Rotavirus) was analysed to examine the impact of pandemic restrictions on vaccine uptake. The timeframes which were compared to determine the effects of COVID-19 were June 2018-December 2019 and March 2020-September 2021. The follow-up rates for paediatric check-ups were consistently lower in the COVID-19 phase, but generally ~90%. Follow-up rates for the vaccinations were distinctly higher during COVID-19. The time between events was almost unchanged for check-ups during the pandemic. For check-ups, age at initial event differed by less than a week between the phases. For vaccinations, the age differences were slightly higher, but exceeded one week in only two cases. The results show that the COVID-19 pandemic had little effect on paediatric check-ups and vaccinations in Germany.
Keywords: COVID-19 pandemic; Germany; IQVIATM disease analyser; SARS-CoV-2; paediatric check-ups; paediatric vaccinations; vaccines.
Conflict of interest statement
R.L., T.C.R. and T.F. are full-time employees of MSD Sharp & Dohme GmbH. H.R. is a full-time employee of IQVIA and has acted as a subcontractor of MSD Sharp & Dohme GmbH in conducting this study.
References
-
- Kling K., Koch J., Vygen-Bonnet S., Wichmann O. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut 2020/2021. Epid. Bull. 2020;34:1–65. doi: 10.25646/7083. - DOI
-
- Benefits of the Statutory Health Insurance in Germany: § 26 SGB V. [(accessed on 7 February 2023)]. Available online: https://www.sozialgesetzbuch-sgb.de.
LinkOut - more resources
Full Text Sources
Miscellaneous